Evidence map›Paper›PMID 29375286›Full record

ArticleFrontiers in neuroscience2017

Does Otovestibular Loss in the Autosomal Dominant Disorder DFNA9 Have an Impact of on Cognition? A Systematic Review.

Jonas De Belder, Stijn Matthysen, Annes J Claes, Griet Mertens, Paul Van de Heyning, Vincent Van Rompaey

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. A systematic review of hearing and vestibular function in carriers of the Pro51Ser mutation in the COCH gene.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Pooled it
  2. Trial
  3. AON-based degradation of c.151C>T mutantMolecular therapy. Nucleic acids · 2021
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jonas De BelderFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Stijn MatthysenFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Annes J ClaesFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Griet MertensFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Paul Van de HeyningFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Vincent Van RompaeyFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEAntwerp University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cognitionDFNA9labyrinth diseasesquality of lifesystematic review

Identifiers

PMID29375286
PMCPMC5767272
OpenAlexW2782689338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.